Literature DB >> 15448356

Feline leukaemia virus LTR variation and disease association in a geographical and temporal cluster.

Chandtip Chandhasin1,2,3, Patricia Lobelle-Rich1,3, Laura S Levy1,2,3.   

Abstract

Feline leukaemia virus (FeLV)-945 was previously identified in natural multicentric lymphomas and contains a 21 bp tandem triplication in the LTR. In the present study, FeLV LTR variation was examined in the cohort from which FeLV-945 was identified. The objectives of the study were to evaluate FeLV LTR variation within the cohort, to determine whether the FeLV-945 LTR was associated uniquely with multicentric lymphoma and to evaluate functional attributes that may have contributed selective advantage to the predominant LTR variants observed. T-cell tumours uniformly contained LTRs with duplicated enhancer sequences, although enhancer duplications conferred little transcriptional advantage. Non-T-cell malignant, proliferative and degenerative diseases contained LTRs with two, three or four tandemly repeated copies of the 21 bp sequence originally identified in FeLV-945. While the length and termini of enhancer duplications were variable, the 21 bp repeat unit was invariant. Triplication of the 21 bp repeat conferred the optimal replicative advantage in feline cells.

Entities:  

Mesh:

Year:  2004        PMID: 15448356     DOI: 10.1099/vir.0.80149-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  15 in total

1.  The frequency of occurrence and nature of recombinant feline leukemia viruses in the induction of multicentric lymphoma by infection of the domestic cat with FeLV-945.

Authors:  Shamim Ahmad; Laura S Levy
Journal:  Virology       Date:  2010-05-06       Impact factor: 3.616

2.  Diminished potential for B-lymphoid differentiation after murine leukemia virus infection in vivo and in EML hematopoietic progenitor cells.

Authors:  Samantha L Finstad; Naomi Rosenberg; Laura S Levy
Journal:  J Virol       Date:  2007-04-11       Impact factor: 5.103

3.  Subtle mutational changes in the SU protein of a natural feline leukemia virus subgroup A isolate alter disease spectrum.

Authors:  Chandtip Chandhasin; Patricia N Coan; Laura S Levy
Journal:  J Virol       Date:  2005-02       Impact factor: 5.103

4.  The surface glycoprotein of a natural feline leukemia virus subgroup A variant, FeLV-945, as a determinant of disease outcome.

Authors:  Lisa L Bolin; Shamim Ahmad; Laura S Levy
Journal:  Vet Immunol Immunopathol       Date:  2011-06-12       Impact factor: 2.046

5.  The surface glycoprotein of feline leukemia virus isolate FeLV-945 is a determinant of altered pathogenesis in the presence or absence of the unique viral long terminal repeat.

Authors:  Lisa L Bolin; Shamim Ahmad; Patricia A Lobelle-Rich; Tara G Ooms; Xavier Alvarez-Hernandez; Peter J Didier; Laura S Levy
Journal:  J Virol       Date:  2013-07-31       Impact factor: 5.103

6.  Unique long terminal repeat and surface glycoprotein gene sequences of feline leukemia virus as determinants of disease outcome.

Authors:  Chandtip Chandhasin; Patricia N Coan; Ivona Pandrea; Chris K Grant; Patricia A Lobelle-Rich; Adriane Puetter; Laura S Levy
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

7.  Substitution of feline leukemia virus long terminal repeat sequences into murine leukemia virus alters the pattern of insertional activation and identifies new common insertion sites.

Authors:  Chassidy Johnson; Patricia A Lobelle-Rich; Adriane Puetter; Laura S Levy
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

Review 8.  Advances in understanding molecular determinants in FeLV pathology.

Authors:  Laura S Levy
Journal:  Vet Immunol Immunopathol       Date:  2008-01-19       Impact factor: 2.046

Review 9.  Viral determinants of FeLV infection and pathogenesis: lessons learned from analysis of a natural cohort.

Authors:  Lisa L Bolin; Laura S Levy
Journal:  Viruses       Date:  2011-09-09       Impact factor: 5.048

10.  Distinctive receptor binding properties of the surface glycoprotein of a natural feline leukemia virus isolate with unusual disease spectrum.

Authors:  Lisa L Bolin; Chandtip Chandhasin; Patricia A Lobelle-Rich; Lorraine M Albritton; Laura S Levy
Journal:  Retrovirology       Date:  2011-05-13       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.